Best treatments for chronic obstructive pulmonary disease
5 products may treat chronic obstructive pulmonary disease, spanning FDA drug classes such as anticholinergic, phosphodiesterase 4 inhibitor, phosphodiesterase 3 inhibitor. The current highest-rated option is tudorza pressair. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 5 drugs we list for chronic obstructive pulmonary disease, 2 are available as lower-cost generics, spanning classes such as anticholinergic, phosphodiesterase 4 inhibitor, phosphodiesterase 3 inhibitor. 2 of 5 carry a safety score, from 70 to 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for chronic obstructive pulmonary disease — so confirm the right choice with your prescriber.
Top-rated picks for chronic obstructive pulmonary disease: 1. Tudorza Pressair · 2. Daliresp · 3. Ohtuvayre
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Powder | Anticholinergic | No data | — | View → | |
| 2 | 70/100 | Prescription | Tablet | Phosphodiesterase 4 Inhibitor | Generic | $10 | View → | |
| 3 | Not yet rated | Prescription | Suspension | Phosphodiesterase 3 Inhibitor | No data | — | View → | |
| 4 | Not yet rated | Prescription | Solution | — | No data | — | View → | |
| 5 | Not yet rated | Prescription | Topical | Phosphodiesterase 4 Inhibitor | Generic | $10 | View → |
Narrow by drug class
Explore the class hubs: phosphodiesterase 4 inhibitor
Full ranking · 5 treatments
tudorza pressair
PrescriptionFDA-sourced
Tudorza Pressair (Aclidinium Bromide) is an anticholinergic used to treat Bronchial Spasm, Chronic Obstructive Pulmonary Disease.
Price varies
daliresp
PrescriptionFDA-sourced
Daliresp (Roflumilast) is a phosphodiesterase 4 inhibitor used to treat Chronic Obstructive Pulmonary Disease.
Pharmacy pays
From ~$9.56/30· 2 formsohtuvayre
PrescriptionFDA-sourced
Ohtuvayre (Ensifentrine) is a phosphodiesterase 3 inhibitor used to treat Chronic Obstructive Pulmonary Disease.
Price varies
yupelri
PrescriptionFDA-sourced
Yupelri (Revefenacin) is a medication used to treat Chronic Obstructive Pulmonary Disease.
Price varies
zoryve
PrescriptionFDA-sourced
Zoryve (Roflumilast) is a phosphodiesterase 4 inhibitor used to treat Chronic Obstructive Pulmonary Disease.
Pharmacy pays
From ~$9.56/30· 2 formsFrequently asked
- What treats chronic obstructive pulmonary disease?
- Our catalog lists 5 products that may treat chronic obstructive pulmonary disease, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is tudorza pressair.
- What is the best-rated treatment for chronic obstructive pulmonary disease?
- By our independent recall-safety rating — not an efficacy measure — tudorza pressair ranks highest among the products we list for chronic obstructive pulmonary disease. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat chronic obstructive pulmonary disease?
- Treatments for chronic obstructive pulmonary disease span FDA drug classes including anticholinergic, phosphodiesterase 4 inhibitor, phosphodiesterase 3 inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status